Results 141 to 150 of about 21,486 (179)

Treatment outcomes of combination versus monotherapy in <i>Stenotrophomonas maltophilia</i> bacteremia: a retrospective single-center analysis. [PDF]

Antimicrob Agents Chemother
Tsai M-H, Chen W-P, Chen C-L, Siu LK, Yu C-M, Shang H-S, Chang F-Y, Lin J-C, Yang Y-S, Wang C-H.   +9 more
europepmc   +1 more source

Different Strains of Microalgae in a Microbial Consortium Remove Antibiotics from Urban Wastewater in Batch and Continuous Treatment Systems. [PDF]

ACS Omega
Vargas SR, de Lima Santos J, Ferraz Ribeiro PH, Alcântara IM, Carneiro RB, Zaiat M.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Head Lice Infestation: Single Drug Versus Combination Therapy With One Percent Permethrin and Trimethoprim/Sulfamethoxazole

Pediatrics, 2001
Background. Head lice infestation (HLI) is a vexing problem for pediatricians and families because lice are becoming resistant to approved antipediculosis agents. Objective.
R B, Hipolito, F G, Mallorca, Z O, Zuniga-Macaraig, P C, Apolinario, J, Wheeler-Sherman   +4 more
openaire   +2 more sources

Micellar Electrokinetic Chromatography as a Valuable Technique for the Quality Control of Drugs Based on the Combination of Sulfamethoxazole with Trimethoprim

Chromatographia, 2003
A micellar electrokinetic chromatographic method is presented for the determination of sulfanilic acid and sulphanilamide as degradation products of sulfamethoxazole and of 3,4,5-trimethoxybenzoic acid as degradation product of trimetoprim, by using 15 mM phosphate buffer (pH 12.6), 20 mM sodium dodecylsulfate and 5% (v/v) acetonitrile as electrolyte ...
Berzas Nevado, Juan José, Castañeda Peñalvo, Gregorio, Guzmán Bernardo, Francisco Javier   +2 more
openaire   +2 more sources

Risk-benefit analyses of drugs: Fundamental considerations and requirements from the point of view of the biometrician. Problems in the assessment of the combination of trimethoprim with sulfamethoxazole

Infection, 1987
Risk-benefit analyses are a prerequisite for a rational decision about therapies, e.g. drugs. Ingredients of a risk-benefit analysis are: 1. quality and quantity of the benefit; 2. quality and quantity of the harm; 3. benefit and harm of the natural history of the disease; 4. benefit and harm of therapeutic alternatives; 5. commensurability of harm and
J, Hasford, N, Victor
openaire   +2 more sources

Combinations of Antimicrobial Drugs: Trimethoprim-Sulfamethoxazole

New England Journal of Medicine, 1974
openaire   +1 more source

A novel sulfamethoxazole derivative as an inhibitory agent against HSP70: A combination of computational with in vitro studies

International Journal of Biological Macromolecules, 2021
Hossein Ghafouri, Asadollah Mohammadi
exaly